Insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cells

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Hao, Cui ^a   Hao, Jiejie ^a   Wang, Wei ^a   Han, Zhangrun ^a   Li, Guangsheng ^a   Zhang, Lijuan ^a   Zhao, Xia ^a   Yu, Guangli ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR; INSULIN SENSITIZING AGENT; MESSENGER RNA; METFORMIN; OLIGOMANNURONATE; OLIGOMANNURONATE CHROMIUM COMPLEX; OLIGOSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; CHROMIUM DERIVATIVE; HEXURONIC ACID; MANNURONIC ACID;

ANIMAL CELL; ARTICLE; BROWN ALGA; CELL STIMULATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENERGY EXPENDITURE; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; INTERNALIZATION; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; CELL LINE; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

PHAEOPHYCEAE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; CELL LINE; CHROMIUM COMPOUNDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE TRANSPORTER TYPE 4; HEXURONIC ACIDS; INSULIN; MICE; MICROSCOPY, CONFOCAL; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 80052832267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024598     Document Type: Article

References (54)

1. Parker JC, (2002) Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus. Adv Drug Deliv Rev 54: 1173-1197.
2. Defronzo RA, (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
3. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104: 12587-12594.
4. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, et al. (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341: 240-246.
5. DeFronzo RA, (2004) Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88: 787-835.
6. Birnbaum MJ, (1989) Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 57: 305-315.
7. James DE, Strube M, Mueckler M, (1989) Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338: 83-87.
8. Winder WW, Hardie DG, (1999) AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277: E1-10.
9. Towler MC, Hardie DG, (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100: 328-341.
10. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
11. DeFronzo RA, Goodman AM, (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 333: 541-549.
12. Wang X, Zheng Y, Fang J, (2004) Recent advances in the study on poly- and oligo-saccharides with hypoglycemic activity. Acta Pharmaceut Sin 39: 1028-1033.
13. Liu B, Liu W, Han BQ, Sun Y, (2007) Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World J Gastroenterol 13: 725-731.
14. Lu X, Chen X, Fu D, Cong W, Ouyang F, (2002) Effect of Amorphophallus Konjac oligosaccharides on STZ-induced diabetes model of isolated islets. Life Sci 72: 711-719.
15. Zhang R, Zhou J, Jia Z, Zhang Y, Gu G, (2004) Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J Ethnopharmacol 90: 39-43.
16. Sahin K, Tuzcu M, Orhan C, Agca CA, Sahin N, et al. (2010) The Effects of Chromium Complex and Level on Glucose Metabolism and Memory Acquisition in Rats Fed High-Fat Diet. Biol Trace Elem Res doi:10.1007/s12011-010-8905-9.
17. Chen X, Fu D, Ouyang F, (2003) Preparation of Cr (III)-Amorphophallus konjac oligosaccharide complex and study on its effect on blood glucose in mice. Chinese J Biochem Pharmaceu 24: 1-3.
18. Haug A, Larsen B, Smidsrod O, (1966) A study of the constitution of alginic acid by partial hydrolysis. Acta Chem Scand 20: 183-190.
19. Natsume M, Kamo Y, Hirayama M, Adachi T, (1994) Isolation and characterization of alginate-derived oligosaccharides with root growth-promoting activities. Carbohydr Res 258: 187-197.
20. Kawada A, Hiura N, Shiraiwa M, Tajima S, Hiruma M, et al. (1997) Stimulation of human keratinocyte growth by alginate oligosaccharides, a possible co-factor for epidermal growth factor in cell culture. FEBS Lett 408: 43-46.
21. Ma J, Xin X, Meng L, Tong L, Lin L, et al. (2008) The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo. PLoS One 3: e3774.
22. Zhang J, Chen Y, Xin X, Li Q, Li M, et al. (2010) Oligomannurarate sulfate blocks tumor growth by inhibiting NF-kappaB activation. Acta Pharmacol Sin 31: 375-381.
23. Fan Y, Hu J, Li J, Yang Z, Xin X, et al. (2005) Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 374: 222-226.
24. Wang S, Li J, Xia W, Geng M, (2007) A marine-derived acidic oligosaccharide sugar chain specifically inhibits neuronal cell injury mediated by beta-amyloid-induced astrocyte activation in vitro. Neurol Res 29: 96-102.
25. Geng M, Xin X, Yang Z, Guan H, Sun G, et al. (2004) Use of oligose alginate in anti-dementia and anti-diabetes. China Patent 200410023827.0, 2004.03.24.
26. Guan H, Lv Z, Zhang D, Yu G, (2006) Pharmaceutical use of alginate oligose sulfate for preventing and treating diabetes. China Patent 200610044581.4, 2006.05.2.
27. Huang S, Czech MP, (2007) The GLUT4 glucose transporter. Cell Metab 5: 237-252.
28. Wang Q, Somwar R, Bilan PJ, Liu Z, Jin J, et al. (1999) Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 19: 4008-4018.
29. Conejo R, Valverde AM, Benito M, Lorenzo M, (2001) Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J Cell Physiol 186: 82-94.
30. Jensen TE, Schjerling P, Viollet B, Wojtaszewski JF, Richter EA, (2008) AMPK alpha1 activation is required for stimulation of glucose uptake by twitch contraction, but not by H2O2, in mouse skeletal muscle. PLoS One 3: e2102.
31. Zhang D, Fujii I, Lin C, Ito K, Guan H, et al. (2008) The stimulatory activities of polysaccharide compounds derived from algae extracts on insulin secretion in vitro. Biol Pharm Bull 31: 921-924.
32. Shara M, Yasmin T, Kincaid AE, Limpach AL, Bartz J, et al. (2005) Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex. J Inorg Biochem 99: 2161-2183.
33. Saltiel AR, Kahn CR, (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
34. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ, (1998) Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373.
35. Krook A, Wallberg-Henriksson H, Zierath JR, (2004) Sending the signal: molecular mechanisms regulating glucose uptake. Med Sci Sports Exerc 36: 1212-1217.
36. Kasuga M, Karlsson FA, Kahn CR, (1982) Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215: 185-187.
37. Chang L, Chiang SH, Saltiel AR, (2004) Insulin signaling and the regulation of glucose transport. Mol Med 10: 65-71.
38. Saltiel AR, Pessin JE, (2003) Insulin signaling in microdomains of the plasma membrane. Traffic 4: 711-716.
39. Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR, (1998) A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. Mol Cell Biol 18: 872-879.
40. Zhang B, Zhou G, Li C, (2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9: 407-416.
41. Rutter GA, Da Silva Xavier G, Leclerc I, (2003) Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375: 1-16.
42. Bergeron R, Russell RR 3rd, Young LH, Ren JM, Marcucci M, et al. (1999) Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 276: E938-944.
43. Zheng D, MacLean PS, Pohnert SC, Knight JB, Olson AL, et al. (2001) Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 91: 1073-1083.
44. Tanaka T, Fujishima Y, Hanano S, Kaneo Y, (2004) Intracellular disposition of polysaccharides in rat liver parenchymal and nonparenchymal cells. Int J Pharm 286: 9-17.
45. Shen W, Hao J, Tian C, Ren J, Yang L, et al. (2008) A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS One 3: e2328.
46. Michael LF, Wu Z, Cheatham RB, Puigserver P, Adelmant G, et al. (2001) Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc Natl Acad Sci U S A 98: 3820-3825.
47. Baar K, Song Z, Semenkovich CF, Jones TE, Han DH, et al. (2003) Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity. FASEB J 17: 1666-1673.
48. Vincent JB, (2004) Recent developments in the biochemistry of chromium(III). Biol Trace Elem Res 99: 1-16.
49. Cefalu WT, Hu FB, (2004) Role of chromium in human health and in diabetes. Diabetes Care 27: 2741-2751.
50. Wang H, Kruszewski A, Brautigan DL, (2005) Cellular chromium enhances activation of insulin receptor kinase. Biochemistry 44: 8167-8175.
51. Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebritsen TS, et al. (1998) Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res 50: 177-182.
52. Davis CM, Vincent JB, (1997) Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36: 4382-4385.
53. Wang YQ, Dong Y, Yao MH, (2009) Chromium picolinate inhibits resistin secretion in insulin-resistant 3T3-L1 adipocytes via activation of amp-activated protein kinase. Clin Exp Pharmacol Physiol 36: 843-849.
54. Kang C, Jin YB, Lee H, Cha M, Sohn ET, et al. (2010) Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food Chem Toxicol 48: 509-516.